查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1526299

COVID-19 檢測的全球市場

COVID-19 Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 1417 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球 COVID-19 檢測市場預計將達到 58 億美元

全球 COVID-19 檢測市場預計 2023 年為 199 億美元，預計到 2030 年將達到 58 億美元，在 2023 年至 2030 年分析期間複合年成長率為 -16.1%。 RT-PCR 檢測套件是本報告分析的細分市場之一，複合年成長率為-16.9%，預計到分析期結束時將達到 39 億美元。在分析期間，免疫分析測試條/盒細分市場的複合年成長率預計為-14.2%。

美國市場預估50億美元，中國預估年複合成長率-31.0%

到 2023 年，美國COVID-19 檢測市場預計將達到 50 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達5,690萬美元，2023-2030年分析期間複合年成長率為-31.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為-15.1%和-14.4%。在歐洲，德國的複合年成長率預計約為-13.8%。

全球 COVID-19 檢測市場 - 主要趨勢與促進因素摘要

COVID-19 檢測是指用於確定一個人是否感染了導致 COVID-19 的 SARS-CoV-2 病毒的方法和過程。有兩種主要類型的測試：檢測病毒本身是否存在的診斷測試，以及識別針對病毒產生的抗體並表明過去感染的血清學測試。診斷測試包括聚合酵素鏈鎖反應（PCR）測試，其準確度很高，被認為是病毒檢測的黃金標準。快速抗原檢測可快速提供結果，但不如 PCR 檢測準確，主要用於高通量環境中的篩檢目的。

在整個大流行期間，情況迅速發展，以滿足不斷成長的需求和各種挑戰。測試技術的創新主要集中在提高準確性、縮短週轉時間和提高可近性。例如，就地檢驗和家庭檢測套組的開發使得在傳統醫療機構之外進行廣泛的檢測成為可能。這些進步將實現更廣泛、更頻繁的檢測，這對於追蹤病毒的傳播和實施及時的隔離和治療策略至關重要。此外，隨著病毒變異，需要持續監測和測試調整，以確保對新變異的敏感性並保持測試的可靠性和有效性。

COVID-19 檢測市場的成長受到技術進步、政府政策和消費行為變化等多種因素的推動。技術創新正在導致更快、更準確的測試的發展，這些測試可以大規模部署，這對於管理疫情和促進安全的社會互動至關重要。政府政策和資金對市場產生了重大影響，在測試基礎設施方面進行了大量投資，以支持公共衛生策略。此外，大流行期間公眾的意識和行為發生了顯著變化。現在對個人健康監測和預防措施的需求不斷成長，包括定期進行 COVID-19 檢測。這項變革正在推動檢測市場的持續成長，並確保檢測仍然是全球健康的關鍵組成部分。

受訪企業範例（總合547家）

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 近期市場趨勢
  • 主要企業
  • 市場趨勢與挑戰
  • 更脆
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP16930

Global COVID-19 Testing Market to Reach US$5.8 Billion by 2030

The global market for COVID-19 Testing estimated at US$19.9 Billion in the year 2023, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of -16.1% over the analysis period 2023-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.9% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth in the Immunoassay Test Strips/Cassettes segment is estimated at -14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at -31.0% CAGR

The COVID-19 Testing market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.9 Million by the year 2030 trailing a CAGR of -31.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of -15.1% and -14.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately -13.8% CAGR.

Global Covid-19 Testing Market - Key Trends and Drivers Summarized

COVID-19 testing refers to the methods and processes used to determine whether a person is infected with the SARS-CoV-2 virus, which causes COVID-19. There are primarily two types of tests: diagnostic tests, which detect the presence of the virus itself, and serological tests, which identify antibodies produced in response to it, indicating past infection. Diagnostic tests include polymerase chain reaction (PCR) tests, which are highly accurate and are considered the gold standard for detecting the virus. Rapid antigen tests provide quicker results but are less accurate than PCR tests and are used primarily for screening purposes in high-throughput environments.

Throughout the pandemic, the landscape of COVID-19 testing has evolved rapidly to meet increasing demands and address various challenges. Innovations in testing technology have focused on increasing accuracy, reducing turnaround times, and enhancing accessibility. For instance, developments in point-of-care testing and at-home testing kits have allowed for broader testing outside traditional healthcare facilities. These advancements have enabled more extensive and frequent testing, which is crucial for tracking the spread of the virus and implementing timely isolation and treatment strategies. Moreover, as the virus mutates, ongoing research and adaptation in testing are necessary to ensure sensitivity to new variants, maintaining the reliability and effectiveness of tests.

The growth in the COVID-19 testing market is driven by several factors, including technological advancements, government policies, and changes in consumer behavior. Technological innovations have led to the development of faster, more accurate tests that can be deployed at scale, which are essential for managing outbreaks and facilitating safe social interactions. Government policies and funding have significantly influenced the market, with massive investments in testing infrastructure to support public health strategies. Additionally, public awareness and behavior have changed markedly during the pandemic; there is now a higher demand for personal health monitoring and preventive practices, which includes regular COVID-19 testing. This shift has encouraged continuous growth in the testing market, ensuring that it remains a critical component of global health.

Select Competitors (Total 547 Featured) -

  • Adaltis Srl
  • Alfa Scientific Designs, Inc.
  • A*STAR Experimental Therapeutics Centre
  • AITbiotech Pte., Ltd.
  • Altimmune, Inc.
  • ADS Biotec, Inc.
  • Accelerate Diagnostics, Inc.
  • AccuBioTech Co., Ltd.
  • Access Bio, Inc.
  • Abwiz Bio Inc.
  • AB Diagnostic Systems GmbH
  • 1drop, Inc.
  • 3B BlackBio Biotech India Ltd.
  • Abacus Diagnostica Oy
  • Aldatu Biosciences

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Types of COVID-19 Testing
    • Different Types of Coronavirus Tests
    • Performance Analysis of COVID-19 Tests
    • Rapid Tests Help in Controlling the Virus
    • Massive Testing to Become a Way of Life
    • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
    • Select Approved COVID-19 Molecular Assay Tests
    • Immunoassays to Witness Fastest Growth
    • Increasing Demand for Antibody Tests
    • How Antibody (Serology) Tests Were Approved and Developed
    • List of US FDA Approved Antigen Tests
    • Nasopharyngeal/Oropharyngeal Swabs Remain Primary Sample Type
    • Diagnostic Laboratories Constitute the Largest End-use Segment
  • RECENT MARKET ACTIVITY
    • Recent Launches
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS AND ISSUES
    • Broader Adoption of Reverse-Transcription Polymerase Chain Reaction-based Diagnostics
    • Increasing Point-of-Care Molecular Testing
    • Accelerated Development and Faster Adoption of New Technologies
    • Expansion of Manufacturing Capacity in Asia and Shift of Supply
    • Positioning for the Future
    • Some Innovative Testing Methods for COVID-19:
  • CRISPR
    • Bioluminescence Testing
    • Lab-on-chip Testing
    • LAMpore Kits
    • Covid-19 NudgeBox Test by DNANudge
    • High Risk of Infection in Geriatric Population Drives COVID-19 Testing Market
    • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
    • Point-of-Care Tests Witness Rapid Growth
    • Innovations and Approvals
    • Portable PoC Test with a Smartphone Reader
    • Saliva Test
    • FDA Approves First Molecular Test for Asymptomatic Patients
    • LumiraDx SARS-CoV-2 Antigen Test
    • Integration of Sophisticated Technology to Drive Market Growth
    • Isothermal Amplification: An Effective Alternative to RT-PCR for COVID-19 Testing
    • A Rapid Genomics Strategy to Trace Coronavirus
    • The pioneering of Rapid Genomics
    • Digital Healthcare Gains Spotlight Amid COVID-19 Pandemic
    • Digital Technologies Gaining Adoption Amid COVID-19
    • List of COVID-19 Contact Tracing Apps
    • Amazon Offers FDA-Approved COVID-19 Test
    • Alliance of BMGF and Life Science Companies Pledge to Improve Access
    • Ensuring the Perfect Mix of COVID-19 Testing
    • Testing Rate & Average Turnaround Time to Results as Key Metrics
    • Growing Significance of Pooled Testing
    • Participation of Public & Private Sector
    • Avoiding Supply Mismatch
    • COVID-19 Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Market Prospects and Outlook
    • US and Europe Dominate, Asia-Pacific to Witness Fastest Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for RT-PCR Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for RT-PCR Assay Kits by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunoassay Test Strips/Cassettes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Immunoassay Test Strips/Cassettes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Nasopharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Nasopharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Oropharyngeal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Oropharyngeal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Nasal Swab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Nasal Swab by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Specimen Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Specimen Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World 7-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 21: World COVID-19 Testing Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • Government of Ontario Introduces Covid-19 Screening Tests at Toronto Pearson International Airport
    • New Federal Rule in Canada for Air Passengers' COVID-19 Tests
    • TABLE 28: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SPAIN
    • TABLE 78: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Spain 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Spain 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • RUSSIA
    • TABLE 84: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Russia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Russia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • AUSTRALIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 106: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Australia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Australia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • INDIA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 112: India Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 113: India 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 115: India 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 119: South Korea 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 121: South Korea 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
    • Authorities Succeed In Successfully Evading the Virus Impact
    • Widespread Roll Out of Testing Laboratories Yields Results
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • LATIN AMERICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2024 & 2030
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 131: Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 133: Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ARGENTINA
    • TABLE 136: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 137: Argentina 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 139: Argentina 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • BRAZIL
    • TABLE 142: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 143: Brazil 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 145: Brazil 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • MEXICO
    • TABLE 148: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 149: Mexico 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 151: Mexico 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 154: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 155: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • MIDDLE EAST
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 160: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 161: Middle East 7-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2024 & 2030
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 163: Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 167: Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • IRAN
    • TABLE 168: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 169: Iran 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 173: Iran 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • ISRAEL
    • TABLE 174: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 175: Israel 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 179: Israel 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • SAUDI ARABIA
    • TABLE 180: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 181: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • UNITED ARAB EMIRATES
    • New Testing Facilities Open Up in the UAE
    • TABLE 186: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 187: UAE 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 191: UAE 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 192: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 193: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030
  • AFRICA
    • COVID-19 Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • COVID-19 Testing Benefits from Existing TB and HIV Laboratory Systems
    • RDTs Arrive in African Countries
    • TABLE 198: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Product - RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 199: Africa 7-Year Perspective for COVID-19 Testing by Product - Percentage Breakdown of Value Revenues for RT-PCR Assay Kits and Immunoassay Test Strips/Cassettes for the Years 2024 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by Specimen Type - Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa 7-Year Perspective for COVID-19 Testing by Specimen Type - Percentage Breakdown of Value Revenues for Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab and Other Specimen Types for the Years 2024 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for COVID-19 Testing by End-Use - Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 203: Africa 7-Year Perspective for COVID-19 Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Diagnostic Centers and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION